- Home
- HCTI vs CLRB Comparison
HCTI vs CLRB Comparison
Compare HCTI & CLRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HCTI
- CLRB
- Stock Information
- Founded
- HCTI 2020
- CLRB 2002
- Country
- HCTI United States
- CLRB United States
- Employees
- HCTI N/A
- CLRB N/A
- Industry
- HCTI Retail: Computer Software & Peripheral Equipment
- CLRB Biotechnology: Pharmaceutical Preparations
- Sector
- HCTI Technology
- CLRB Health Care
- Exchange
- HCTI Nasdaq
- CLRB Nasdaq
- Market Cap
- HCTI 13.5M
- CLRB 14.2M
- IPO Year
- HCTI 2021
- CLRB N/A
- Fundamental
- Price
- HCTI $0.05
- CLRB $4.92
- Analyst Decision
- HCTI
- CLRB Hold
- Analyst Count
- HCTI 0
- CLRB 2
- Target Price
- HCTI N/A
- CLRB N/A
- AVG Volume (30 Days)
- HCTI 506.0M
- CLRB 166.5K
- Earning Date
- HCTI 08-18-2025
- CLRB 08-12-2025
- Dividend Yield
- HCTI N/A
- CLRB N/A
- EPS Growth
- HCTI N/A
- CLRB N/A
- EPS
- HCTI N/A
- CLRB N/A
- Revenue
- HCTI $11,291,000.00
- CLRB N/A
- Revenue This Year
- HCTI N/A
- CLRB N/A
- Revenue Next Year
- HCTI N/A
- CLRB N/A
- P/E Ratio
- HCTI N/A
- CLRB N/A
- Revenue Growth
- HCTI N/A
- CLRB N/A
- 52 Week Low
- HCTI $0.01
- CLRB $4.36
- 52 Week High
- HCTI $1.90
- CLRB $69.00
- Technical
- Relative Strength Index (RSI)
- HCTI 61.78
- CLRB 37.58
- Support Level
- HCTI $0.05
- CLRB $4.89
- Resistance Level
- HCTI $0.09
- CLRB $5.85
- Average True Range (ATR)
- HCTI 0.01
- CLRB 0.34
- MACD
- HCTI 0.01
- CLRB 0.15
- Stochastic Oscillator
- HCTI 55.07
- CLRB 15.95
About HCTI Healthcare Triangle Inc.
Healthcare Triangle Inc is a healthcare information technology company focused on advancing industry-transforming solutions in the sectors of cloud services, data science, and professional and managed services for the healthcare and life sciences industry. The company reinforces healthcare progress through technology and extensive industry know-how. HTI supports healthcare providers and payors, hospitals, and Pharma Life Sciences organizations in their effort to improve health outcomes by enabling the adoption of new technologies, data enlightenment, business agility, and accelerated response to immediate business needs and competitive threats. It provides services under three operating segments: Software Services, Managed Services, and Support and Platform Services.
About CLRB Cellectar Biosciences Inc.
Cellectar Biosciences Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of drugs for the treatment of cancer. The company's core objective is to leverage a proprietary phospholipid drug conjugate (PDC) delivery platform to develop PDCs that are designed to specifically target cancer cells and deliver improved efficacy and safety as a result of fewer off-target effects. It has one operating and reportable segment focused on utilizing its PDC platform to develop drugs for the treatment of cancer.